Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | THRB | P10828 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | P2RX3 | P56373 | 1/20 | 0.30 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27192282 | 1.00 | LMNA (0.33) | LMNATHRBALDH1A1CYP1A2CYP3A4 | |
| SCHEMBL27192054 | 0.96 | LMNA (0.33) | LMNATHRBALDH1A1CYP1A2CYP3A4 | |
| SCHEMBL30702000 | 0.96 | LMNA (0.33) | LMNATHRBALDH1A1CYP1A2CYP3A4 | |
| SCHEMBL30702077 | 0.89 | CYP1A2 (0.32) | LMNATHRBALDH1A1CYP1A2CYP3A4 | |
| SCHEMBL27191908 | 0.89 | CYP1A2 (0.32) | LMNATHRBALDH1A1CYP1A2CYP3A4 | |
| SCHEMBL27191786 | 0.88 | LMNA (0.30) | LMNATHRB | |
| SCHEMBL30702015 | 0.88 | LMNA (0.30) | LMNATHRB | |
| SCHEMBL30702018 | 0.88 | LMNA (0.30) | LMNATHRB | |
| SCHEMBL27192032 | 0.88 | ALDH1A1 (0.32) | ALDH1A1CYP1A2CYP3A4HPGDHSD17B10 | |
| SCHEMBL27192053 | 0.88 | LMNA (0.30) | LMNATHRBALDH1A1CYP1A2CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4565574-A1 | SARS-COV2 MAIN PROTEASE INHIBITORS | GILEAD SCIENCES, INC. (US) | 2025-06-11 | — | — | EP | disclosed |
| CN-119731159-A | SARS-CoV2 main proteinase inhibitor | 吉利德科学公司 | 2025-03-28 | — | — | CN | disclosed |
| WO-2024031089-A1 | SARS-COV2 MAIN PROTEASE INHIBITORS | GILEAD SCIENCES, INC. (US) | 2024-02-08 | — | — | WO | disclosed |